Elevated IL-8 levels in MKs, independent of SARS-CoV-2 variant type, and in the plasma of COVID-19 patients suggest that IL-8 may serve as a biomarker for platelet hyperreactivity and thrombotic events associated with COVID-19. The gene discussed is CXCL8; the disease is COVID-19.